These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33172012)

  • 1. Fragment Library of Natural Products and Compound Databases for Drug Discovery.
    Chávez-Hernández AL; Sánchez-Cruz N; Medina-Franco JL
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
    Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
    Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
    [No Abstract]   [Full Text] [Related]  

  • 3. Databases for the targeted COVID-19 therapeutics.
    Wang Y; Li F; Zhang Y; Zhou Y; Tan Y; Chen Y; Zhu F
    Br J Pharmacol; 2020 Nov; 177(21):4999-5001. PubMed ID: 32845521
    [No Abstract]   [Full Text] [Related]  

  • 4. A Fragment Library of Natural Products and its Comparative Chemoinformatic Characterization.
    Chávez-Hernández AL; Sánchez-Cruz N; Medina-Franco JL
    Mol Inform; 2020 Nov; 39(11):e2000050. PubMed ID: 32302465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.
    Conti A; Lasagni C; Bigi L; Pellacani G
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e360-e361. PubMed ID: 32379913
    [No Abstract]   [Full Text] [Related]  

  • 7. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
    Shahzad F; Anderson D; Najafzadeh M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on antiviral antibody-based biopharmaceuticals.
    Ahangarzadeh S; Payandeh Z; Arezumand R; Shahzamani K; Yarian F; Alibakhshi A
    Int Immunopharmacol; 2020 Sep; 86():106760. PubMed ID: 32645633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
    Liu M; Quinn RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovering small-molecule therapeutics against SARS-CoV-2.
    Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR
    Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
    Berretta AA; Silveira MAD; Cóndor Capcha JM; De Jong D
    Biomed Pharmacother; 2020 Nov; 131():110622. PubMed ID: 32890967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.
    Singh N; Chaput L; Villoutreix BO
    J Chem Inf Model; 2020 Aug; 60(8):3910-3934. PubMed ID: 32786511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative SARS-CoV-2 M
    Mazzini S; Musso L; Dallavalle S; Artali R
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32824454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Drug Candidates with Various SARS-CoV-2 Receptors: An in Silico Study to Combat COVID-19.
    Barros RO; Junior FLCC; Pereira WS; Oliveira NMN; Ramos RM
    J Proteome Res; 2020 Nov; 19(11):4567-4575. PubMed ID: 32786890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating devastating COVID-19 by drug repurposing.
    Pawar AY
    Int J Antimicrob Agents; 2020 Aug; 56(2):105984. PubMed ID: 32305589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.
    Olubiyi OO; Olagunju M; Keutmann M; Loschwitz J; Strodel B
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32668701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updating and profiling the natural product-likeness of Latin American compound libraries.
    Gómez-García A; Prinz AK; Jiménez DAA; Zamora WJ; Barazorda-Ccahuana HL; Chávez-Fumagalli MÁ; Valli M; Andricopulo AD; da S Bolzani V; Olmedo DA; Solís PN; Núñez MJ; Rodríguez Pérez JR; Sánchez HAV; Cortés Hernández HF; Mosquera Martinez OM; Koch O; Medina-Franco JL
    Mol Inform; 2024 Jul; 43(7):e202400052. PubMed ID: 38994633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
    Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
    ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a 3D-shaped, natural product like fragment library by fragmentation and diversification of natural products.
    Prescher H; Koch G; Schuhmann T; Ertl P; Bussenault A; Glick M; Dix I; Petersen F; Lizos DE
    Bioorg Med Chem; 2017 Feb; 25(3):921-925. PubMed ID: 28011199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.